-
Mashup Score: 6
A whole food, plant-based diet has shown benefits for patients with chronic kidney disease (CKD).
Source: www.docwirenews.comCategories: General Medicine News, Partners & KOLsTweet
-
Mashup Score: 1Lucia Masarova, MD, on Transfusion-Related Cost Findings From SIMPLIFY-1 | Docwire News - 2 month(s) ago
Dr. Lucia Masarova described data on ruxolitinib versus momelotinib from SIMPLIFY-1 comparing total medical cost and time burden related to outpatient transfusion in myelofibrosis.
Source: www.docwirenews.comCategories: General Medicine News, Partners & KOLsTweet
-
Mashup Score: 1Heme Today | Docwire News - 2 month(s) ago
Heme Today covers the latest news and analyses in bleeding, clotting, red blood cell, and iron disorders for hematologists and oncologists focused on bleeding disorders.
Source: www.docwirenews.comCategories: General Medicine News, Partners & KOLsTweet
-
Mashup Score: 0Zahra Pakbaz, MD, Describes the Value of a Dedicated Classical Hematology Clinic | Docwire News - 2 month(s) ago
Dr. Pakbaz, from the University of California Irvine, shared data on the value of a dedicated classical hematology clinic.
Source: www.docwirenews.comCategories: General Medicine News, Partners & KOLsTweet
-
Mashup Score: 0VTE in Hemophilia Appears Rare After Total-Joint Replacement Even Without Prophylaxis | Docwire News - 2 month(s) ago
Patients with hemophilia A or B had low rates of symptomatic venous thromboembolism after total-joint replacement despite infrequent usage of thromboprophylaxis
Source: www.docwirenews.comCategories: General Medicine News, Partners & KOLsTweet
-
Mashup Score: 2CheckMate 8HW: Nivolumab Plus Ipilimumab Offers Better PFS for mCRC Over Chemotherapy Alone | Docwire News - 3 month(s) ago
At ASCO GI 2024, Dr. Thierry Andre presented the first results of the CheckMate 8HW study on the use of nivolumab plus ipilimumab versus chemotherapy and nivolumab monotherapy.
Source: www.docwirenews.comCategories: Expert PicksTweet
-
Mashup Score: 1EMERALD-1: Durvalumab Plus Bevacizumab With TACE Versus TACE Monotherapy | Docwire News - 3 month(s) ago
Dr. Riccardo Lencioni presented new data from the EMERALD-1 study on combining TACE plus durvalumab with and without bevacizumab.
Source: www.docwirenews.comCategories: General Medicine News, Partners & KOLsTweet
-
Mashup Score: 2
Dr. Christopher Lieu gives an overview of some of the top presentations and data to look out for at ASCO GI 2024, and discusses the importance of the event.
Source: www.docwirenews.comCategories: Expert PicksTweet
-
Mashup Score: 2
Dr. Christopher Lieu gives an overview of some of the top presentations and data to look out for at ASCO GI 2024, and discusses the importance of the event.
Source: www.docwirenews.comCategories: Expert PicksTweet
-
Mashup Score: 9
Drs. Hossein Borghaei and Tony Calles join Dr. Nabhan to dissect cutting-edge data from the ESMO Congress 2023, spotlighting the transformative landscape of lung cancer treatment.
Source: www.docwirenews.comCategories: General Medicine News, Onc News and JournalsTweet
Whole Food, Plant-Based Diets for Patients With CKD | Docwire News https://t.co/iG1Q1CKIpC